Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions are characterized by enthusiastic acknowledgment of the long-term benefits, such as reports that 82% of participants improved and 67% no longer met PTSD criteria, with terminology like 'impressive,' 'promising,' and 'impactful' reflecting strong positive sentiment. The tone and choice of words reveal a high level of engagement and belief that this research could significantly influence PTSD treatment practices.
Most discussions support the positive findings and potential of MDMA-assisted psychotherapy for PTSD, reflecting strong agreement with the research.
Posts demonstrate high curiosity, with references to study details, long-term effects, and the significance of results, indicating high interest.
Several discussions critically analyze treatment protocols and implications, showing deep engagement with the research outcomes.
The posts emphasize the groundbreaking nature of the findings, highlighting potential changes in treatment approaches and policy, indicating high impact.
The federal government needs to decriminalize all schedule 1 drugs https://t.co/4UuqJRuWnc
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials | SpringerLink https://t.co/gjnnOwi6Rl
So proud to see the results of @MAPS's Phase II MDMA trials in print in the Psychopharmacology journal as I make my annual donation. If you are just getting interested in #psychedelics, please read the literature. It is important. https://t.co/PsQPEDvQlk https://t.co/6RP81Q1G9E
@1goodtern Here is longitudinal study on impact of treating PTSD which I infer can apply well to deficient compassion: https://t.co/h3XbeFu3es
Meanwhile, a few lanes over
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials. - Abstract - Europe PMC https://t.co/pQChEnyOgy
This video discusses the long-term effects of MDMA-assisted psychotherapy for PTSD, showing significant symptom reduction lasting at least 12 months, improved relationships, and well-being, with minimal adverse effects…
This study analyzed the long-term effects of MDMA-assisted psychotherapy on individuals with PTSD, showing significant reductions in symptoms that persisted 12 months after treatment. Participants experienced fewer…
RETRACTION: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials We wish to inform the r/science community of an article submitted to the subreddit that has since been retracted by the journal.…
@chrisaikenmd @PMasand MDMA-AP trial doc here. Few reasons: 1) low dose MDMA seems to be more stimulating than empathogenic, presenting unique challenges 2) there's lotsa active placebo data from phase 1 & 2 trials. The FDA recognizes unblinding is impossible to avoid. https://t.co/R1Q6mXC7tJ
@RandomBunnyTalk one more https://t.co/Z2gCFSg6Cv
@N_Gukasyan @MarkLRuffalo Conflating medical ketamine for TRD, often without any accompanying therapy, with all other psychedelic-assisted psychotherapy is misguided. https://t.co/Ft3KF79TPc https://t.co/zaZax6leOr
@MarkLRuffalo The results from MDMA-assisted psychotherapy for PTSD suggests otherwise. Effects tended to increase 12 months after completion. https://t.co/Ft3KF79TPc
@MauVega_Vivas Échale un ojo. Los resultados son impactantes y científicamente controlados. Es un protocolo serio. Saludos cordiales. https://t.co/ICDdzrDTuA
@TriniGancedo @DrJoaquinMateu https://t.co/r4Qt7Jgofs
@1goodtern Here is longitudinal study on impact of treating PTSD which I infer can apply well to deficient compassion: https://t.co/h3XbeFu3es
here's the research article that inspired @theburnoutprof's quote
RT @Psychedelic_Med: Because #psychedelicscience has only recently been able to resume, many studies have not observed effects on longer ti…
Because #psychedelicscience has only recently been able to resume, many studies have not observed effects on longer timescales. This longitudinal analysis of #MDMAtherapy for PTSD found symptom improvement for at least a year following treatment. https://t.co/PTHbCtlf8V
@joarhalvorsen @jkmjel Det betyr ikke at man ikke har målt effekt over lenger tid; fase-2 studiene indikerer faktisk økt effekt over tid (er det tilfellet for TFP?): "symptom improvement continued at least 12 months post-treatment." https://t.co/wrXjakjm4E
@CoyneoftheRealm This is probably best data as of yet when it comes to longer-term: https://t.co/mSFpYMGFao
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials [Scott Hamilton, Berra Yazar-Klosinski, et al. Psychopharmacology (Berl). 2020; 237(8): 2485–2497.] https://t.co/dkeBf92Mxv https://t.co/mWi5dEerGZ
The federal government needs to decriminalize all schedule 1 drugs https://t.co/4UuqJRuWnc
RT @briandavidearp: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of si…
RT @briandavidearp: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of si…
RT @briandavidearp: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of si…
RT @briandavidearp: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of si…
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials. - Abstract - Europe PMC https://t.co/pQChEnyOgy
RT @Nick_Pateras: So proud to see the results of @MAPS's Phase II MDMA trials in print in the Psychopharmacology journal as I make my annua…
So proud to see the results of @MAPS's Phase II MDMA trials in print in the Psychopharmacology journal as I make my annual donation. If you are just getting interested in #psychedelics, please read the literature. It is important. https://t.co/PsQPEDvQlk https://t.co/6RP81Q1G9E
@BlusClues_ @Psych_Fin @MAPS paper: https://t.co/NO1V3Tqm28
MDMA-assisted psychotherapy for treatment of Post Traumatic Stress Disorder https://t.co/58AB1uP6KN Original paper https://t.co/e54oqh9QHy
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials https://t.co/AP9Mp2oBM9
RT @Chacruna_net: Long-term follow-up outcomes (>1 year) after the final MDMA-assisted therapy session demonstrated that 82% of participant…
RT @Chacruna_net: Long-term follow-up outcomes (>1 year) after the final MDMA-assisted therapy session demonstrated that 82% of participant…
RT @Chacruna_net: Long-term follow-up outcomes (>1 year) after the final MDMA-assisted therapy session demonstrated that 82% of participant…
#MDMA Cures 67% of people with #PTSD, measured > 12 months after treatment !!! https://t.co/FW8BQ4qKqM
RT @Chacruna_net: Long-term follow-up outcomes (>1 year) after the final MDMA-assisted therapy session demonstrated that 82% of participant…
RT @PsydelicsToday: Long-term Follow-Up Outcomes of MDMA-assisted Psychotherapy for Treatment of PTSD: A Longitudinal Pooled Analysis of Si…
RT @Chacruna_net: Long-term follow-up outcomes (>1 year) after the final MDMA-assisted therapy session demonstrated that 82% of participant…
RT @Chacruna_net: Long-term follow-up outcomes (>1 year) after the final MDMA-assisted therapy session demonstrated that 82% of participant…
Long-term follow-up outcomes (>1 year) after the final MDMA-assisted therapy session demonstrated that 82% of participants exhibited clinically significant PTSD symptom improvement, while 67% of participants no longer met diagnostic criteria for PTSD. https://t.co/UtNg2BZekh https://t.co/Lw7uCJg0Il
https://t.co/cuZuG3Q3o1
RT @PsydelicsToday: Long-term Follow-Up Outcomes of MDMA-assisted Psychotherapy for Treatment of PTSD: A Longitudinal Pooled Analysis of Si…
RT @PsydelicsToday: Long-term Follow-Up Outcomes of MDMA-assisted Psychotherapy for Treatment of PTSD: A Longitudinal Pooled Analysis of Si…
Long-term Follow-Up Outcomes of MDMA-assisted Psychotherapy for Treatment of PTSD: A Longitudinal Pooled Analysis of Six Phase 2 Trials https://t.co/Q1hmBO2JLZ
RT @BeckleyResearch: The most comprehensive analysis yet of the safety & durability of treatment outcomes following #MDMA-assisted psychoth…
RT @wendyburn: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six pha…
RT @BeckleyResearch: The most comprehensive analysis yet of the safety & durability of treatment outcomes following #MDMA-assisted psychoth…
RT @BeckleyResearch: The most comprehensive analysis yet of the safety & durability of treatment outcomes following #MDMA-assisted psychoth…
RT @wendyburn: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six pha…
RT @wendyburn: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six pha…
RT @wendyburn: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six pha…
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials | SpringerLink https://t.co/gjnnOwi6Rl
@Horacio_Staines El enlace es al foro en reddit/r/science donde se presentan y comentan investigaciones. A su vez enlaza al artículo en prensa popular (en alemán). Si quieres echarte un clavado a los detalles, tienes que dar con el "paper" publicado en Psychopharmacology https://t.co/bKMWG9slKg
Le MDMA (ecstasy) serait utile avec une psychothérapie pour les gens ayant du stress post traumatique. Alors il y a pas de groupe contrôle mais ...97% d'amélioration plus ou moins durable c'est juste ouf comme effet. Enfin sauf erreur de ma part ^^ https://t.co/39cmY2iErS
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials El estudio o "paper" publicado en Psychopharmacology 4-jun-2020 https://t.co/5CEDYluQ9Z
Då snackar alltså om en "kort" behandling: tio terapisamtal plus två längre MDMA-sessioner. Även vid kronisk PTSD. Imponerande! Behandlingen kräver två terapeuter hela vägen igenom, så det kommer kosta en del när det väl rullas ut i vården inom 3-4 år. https://t.co/2mTCg5AqSc
Meanwhile, a few lanes over
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials | SpringerLink https://t.co/hY8qQGEv5i
RT @MichaelHaichin: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: analysis of six phase 2 trials "The…
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: analysis of six phase 2 trials "The number of participants who no longer met PTSD criteria increased from treatment exit (56.0%) to long-term follow-up (67.0%)." https://t.co/MaszSIUq5e
MDMA assisted psychotherapy reduces PTSD https://t.co/rHVsuWqoc9
Promising results from the Long-term Follow-Up Outcomes of MDMA-assisted Psychotherapy for the Treatment of PTSD! https://t.co/oHKcXZb3Bh
u/shiruken. Retract 10.1007/s00213-020-05548-2. 10:26 AM Sep 2, 2024. View View revision ; u/shiruken. Retracted 10.1016/j.surfin.2024.104081. 8:20 AM Jun 1, ...
https://doi.org/10.1007/s00213-013-3304-5. Adamson, S., & Metzner, R. (1988) ... 020-05548-2. Kahlig, K. M., Binda, F., Khoshbouei, H., Blakely, R. D. ...
https://doi.org/10.1007/s00213-020-05548-2 6.Johansen, P., & Krebs, T. (2009). How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale ...
... 10.1007/s00213-021-05978-6. Yehuda, R.; Sodickson, D.K.; Weiner, M.W.; Marmar ... 020-05548-2 ments for posttraumatic stress disorder in adults : A ...
https://doi.org/10.1007/s00213-020-05548-2. Krediet, E., Bostoen, T., Breeksema, J., van Schagen, A., Passie, T. ve Vermetten, E. (2020). Reviewing the ...
org/10.1007/s00213-020-05548-2) 라는 기사 가 2024년 8월 10일부로 Psychopharmacology에서 철회되었습니다 . 밴쿠버, 캐나다의 MP-4 연구 현장 ...
... 10.1007/s00213-019-05249-5). 2. L Jerome et al, RETRACTED, Psychopharmacology, 2020, 237, 2485 (DOI: 10.1007/s00213-020-05548-2). 3. A A ...
... 10.1007/s00213-020-05548-2; Michael C. Mithoefer , Allison A. Feduccia , Lisa Jerome , Anne Mithoefer , Mark Wagner , Zach Walsh , Scott ...
Published June 13, 2024. Accessed Aug. 12, 2204. Jerome L, et al. Psychopharmacol. 2024;doi:10.1007/s00213-020-05548-2.
... 10.1007/s00213-020-05548-2#citeas #frontlineworkers#frontline#ptsd#ptsdawareness#emergency#police#paramedic#fireemergencyservices ...
doi: 10.1007/s00213-020-05548-2. Epub 2020 Jun 4. PMID: 32500209; PMCID: PMC7351848. 2 O'Neil, M.J., The Merck Index: An Encyclopedia of ...
... 10.1007/s00213-020-05548-2 Mitchel and other (June 2021). "MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo ...
https://doi.org/10.1007/s00213-020-05548-2. Serafini, G., Howland, R. H., Rovedi, F., Girardi, P., & Amore, M. (2014) The role of ketamine in ...
CB
WC
NP
CC
TH
BD
H
DM
MS
BH
GK
JT
N
PS
PA
AW
TH
A
MW
PA
N
SM
EL
JO
SP
PC
HP
L
P
SY
C
E
SK
CI
L
TF
?
PT
B
DZ
VS
TC
CP
BG
J
DB
K
LW
HT
MH
TP
MN